CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD
23rd May 2022 Uncategorised 0Positive opinion is based on data from clinical trials which showed improvement in lung function More: CHMP recommends Sanofi’s Xenpozyme for rare disease ASMD Source: News
read more